Navigation Links
Neusoft to Invest in Israeli Medical Solutions Company for Accelerating Expansion in Global Healthcare Service Market

SHENYANG, China, April 26, 2011 /PRNewswire-Asia/ -- Neusoft Corporation ("Neusoft", 600718.SH), a leading IT solution and service provider in China, recently announced that its wholly-owned subsidiary Neusoft Europe Inc. ("Neusoft Europe") has signed a subscription agreement with Aerotel Medical Systems Ltd. ("Aerotel"), a leading global manufacturer of modular, mobile and home based telemedicine and telecare solutions based in Israel, under which Neusoft Europe will subscribe for 26915 shares of Aerotel with 1.77 million US Dollars to hold 30.77% of its outstanding shares. This transaction will enable Neusoft to obtain more resources and further accelerate its steps entering into the global healthcare service market.


Currently this transaction is subject to regulatory approvals in China.

With medical business as one of its major businesses, Neusoft has been engaged in medical equipment, medical IT solutions and healthcare services over the past 10 years and has become China's market leader in the industry. Meanwhile, the company has been actively expanding in the global market, and its medical equipment is exported to approximately 60 countries and regions across the globe. By integrating with Aerotel's leading expertise in healthcare service, Neusoft will greatly improve the overall competency of its existing healthcare service business, and quickly extend its advantages in China to Europe and the global market.

Aerotel, with more than a decade of rich experience in this industry, has been maintaining strong innovative technology capabilities and a widely-covered sales network with a client base in over 40 countries and regions around the globe. By partnering with Neusoft, Aerotel will gain more capital to support its R&D and business growth, and enhance the competitiveness of its products and services in the global market.

"We are delighted to establish a close strategic partnership with Aerotel," said Dr. Liu Jiren, Chairman & CEO of Neusoft Corporation. "Aerotel's excellent sales network, products and R&D talent will bring new growth momentum to Neusoft and enable us to enrich our healthcare service portfolio, strengthen the global delivery capacity, create more value to our customers, and significantly promote our business expansion in European and global healthcare markets."

About NeusoftNeusoft is the leading IT solution and service provider in China with operations across the globe. Focusing on software technology, Neusoft provides industry solutions, product engineering solutions and related software products & platforms, and services. For more information, please visit:

About AerotelAerotel Medical Systems is a leading global manufacturer of modular, mobile and home based telemedicine and telecare solutions, designed to transfer essential medical and lifestyle data over the telephone, mobile phone, wireless, the Internet and other electronic media. For more information, please visit: http://www.aerotel.comFor more information, please contact:Terry DuPR ManagerNeusoft CorporationPhone: +86-24-8366-2306Email:

SOURCE Neusoft Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
3. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
4. ( Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
5. CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway
6. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
7. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
8. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
9. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
Post Your Comments:
(Date:6/26/2016)... , June 26, 2016 ... care operating models within the health care industry is ... financial efficiency , Deloitte offers a suite of ... business issues impacting efficient cost optimization: labor resource analysis, ... These services facilitate better outcomes and better economics ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... , June 24, 2016 ... of the "Structural Electronics 2015-2025: Applications, Technologies, ... In-Mold Electronics, Smart Skin, ... Photovoltaics Structural electronics involves electronic ... load-bearing, protective structures, replacing dumb structures such as ...
Breaking Medicine Technology:
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):